Rocket Pharmaceuticals (NASDAQ:RCKTW) Trading Up 45.8%

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKTWGet Free Report) shares were up 45.8% during trading on Tuesday . The company traded as high as $0.12 and last traded at $0.12. Approximately 101 shares were traded during trading, a decline of 100% from the average daily volume of 22,645 shares. The stock had previously closed at $0.09.

Rocket Pharmaceuticals Trading Up 45.8 %

The stock has a 50-day moving average of $0.17 and a 200 day moving average of $0.29.

Rocket Pharmaceuticals Company Profile

(Get Free Report)

Rocket Pharmaceuticals, Inc, together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells or promotes the production of faulty blood cells; leukocyte adhesion deficiency-I, a genetic disorder that causes the immune system to malfunction; and pyruvate kinase deficiency, a rare red blood cell autosomal recessive disorder that results in chronic non-spherocytic hemolytic anemia.

Recommended Stories

Receive News & Ratings for Rocket Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rocket Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.